Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009
Published online before print June 18, 2009, doi: 10.1161/CIRCRESAHA.109.199547
A more recent version of this article appeared on July 17, 2009
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
105/2/185    most recent
CIRCRESAHA.109.199547v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Figtree, G. A.
Right arrow Articles by Rasmussen, H. H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Figtree, G. A.
Right arrow Articles by Rasmussen, H. H.
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow Congestive
Right arrow ACE/Angiotension receptors
Right arrow Oxidant stress

Submitted on October 31, 2008
Revised on May 21, 2009
Accepted on June 10, 2009

Reversible Oxidative Modification. A Key Mechanism of Na+-K+ Pump Regulation

Gemma A. Figtree ; Chia-Chi Liu ; Stephanie Bibert ; Elisha J. Hamilton ; Alvaro Garcia ; Caroline N. White ; Karin K.M. Chia ; Flemming Cornelius ; Kaethi Geering ; and Helge H. Rasmussen *

From the North Shore Heart Research Group (G.A.F., C.-C.L., E.J.H., C.N.W., K.K.M.C., H.H.R.), Kolling Institute, University of Sydney, Australia; Department of Cardiology (G.A.F., A.G., K.K.M.C., H.H.R.), Royal North Shore Hospital, Sydney, Australia; Department of Pharmacology and Toxicology (S.B., K.G.), University of Lausanne, Switzerland; and Department of Physiology and Biophysics (F.C.), Aarhus University, Denmark.

* To whom correspondence should be addressed. E-mail: helger{at}med.usyd.edu.au.

Angiotensin II (Ang II) inhibits the cardiac sarcolemmal Na+-K+ pump via protein kinase (PK)C-dependent activation of NADPH oxidase. We examined whether this is mediated by oxidative modification of the pump subunits. We detected glutathionylation of {beta}1, but not {alpha}1, subunits in rabbit ventricular myocytes at baseline. {beta}1 Subunit glutathionylation was increased by peroxynitrite (ONOO-), paraquat, or activation of NADPH oxidase by Ang II. Increased glutathionylation was associated with decreased {alpha}1/{beta}1 subunit coimmunoprecipitation. Glutathionylation was reversed after addition of superoxide dismutase. Glutaredoxin 1, which catalyzes deglutathionylation, coimmunoprecipitated with {beta}1 subunit and, when included in patch pipette solutions, abolished paraquat-induced inhibition of myocyte Na+-K+ pump current (Ip). Cysteine (Cys46) of the {beta}1 subunit was the likely candidate for glutathionylation. We expressed Na+-K+ pump {alpha}1 subunits with wild-type or Cys46-mutated {beta}1 subunits in Xenopus oocytes. ONOO- induced glutathionylation of {beta}1 subunit and a decrease in Na+-K+ pump turnover number. This was eliminated by mutation of Cys46. ONOO- also induced glutathionylation of the Na+-K+ ATPase {beta}1 subunit from pig kidney. This was associated with a {approx}2-fold decrease in the rate-limiting E2->E1 conformational change of the pump, as determined by RH421 fluorescence. We propose that kinase-dependent regulation of the Na+-K+ pump occurs via glutathionylation of its {beta}1 subunit at Cys46. These findings have implications for pathophysiological conditions characterized by neurohormonal dysregulation, myocardial oxidative stress and raised myocyte Na+ levels.


Key words: glutathionylation • glutaredoxin • Na+-K+ pump • angiotensin • NADPH oxidase